ICUI
Income statement / Annual
Last year (2023), ICU Medical, Inc.'s total revenue was $2.26 B,
a decrease of 0.92% from the previous year.
In 2023, ICU Medical, Inc.'s net income was -$29.66 M.
See ICU Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.26 B
|
$2.28 B
|
$1.32 B
|
$1.27 B
|
$1.27 B
|
$1.40 B
|
$1.29 B
|
$379.37 M
|
$341.67 M
|
$309.26 M
|
| Cost of Revenue |
$1.52 B |
$1.58 B |
$824.82 M |
$809.51 M |
$794.34 M |
$830.01 M |
$866.52 M |
$177.97 M |
$160.87 M |
$157.86 M |
| Gross Profit |
$739.87 M |
$697.76 M |
$491.49 M |
$461.50 M |
$471.86 M |
$570.03 M |
$426.10 M |
$201.40 M |
$180.80 M |
$151.40 M |
| Gross Profit Ratio |
0.33 |
0.31 |
0.37 |
0.36 |
0.37 |
0.41 |
0.33 |
0.53 |
0.53 |
0.49 |
| Research and Development
Expenses |
$85.34 M
|
$92.98 M
|
$47.50 M
|
$42.95 M
|
$48.61 M
|
$52.87 M
|
$51.25 M
|
$12.96 M
|
$15.71 M
|
$18.33 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$276.88 M
|
$328.15 M
|
$303.95 M
|
$89.43 M
|
$1.80 M
|
$88.94 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$100,000.00
|
$600,000.00
|
$200,000.00
|
$100,000.00
|
$81.42 M
|
$100,000.00
|
| Selling, General &
Administrative Expenses |
$606.69 M
|
$608.35 M
|
$302.58 M
|
$283.95 M
|
$276.98 M
|
$328.15 M
|
$303.95 M
|
$89.43 M
|
$83.22 M
|
$88.94 M
|
| Other Expenses |
$25.01 M |
-$5.14 M |
$127,000.00 |
-$975,000.00 |
$5.74 M |
$1.47 M |
-$2.48 M |
$767,000.00 |
$1.13 M |
$755,000.00 |
| Operating Expenses |
$717.05 M |
$701.33 M |
$350.21 M |
$325.93 M |
$331.33 M |
$381.01 M |
$355.21 M |
$102.38 M |
$98.93 M |
$107.27 M |
| Cost And Expenses |
$2.24 B |
$2.28 B |
$1.18 B |
$1.14 B |
$1.13 B |
$1.21 B |
$1.22 B |
$280.36 M |
$259.80 M |
$265.13 M |
| Interest Income |
$7.51 M |
$4.43 M |
$2.80 M |
$3.70 M |
$6.80 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$102.73 M |
$66.38 M |
$858,000.00 |
$1.75 M |
$549,000.00 |
$709,000.00 |
$2.05 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$228.77 M
|
$258.80 M
|
$99.29 M
|
$94.85 M
|
$85.21 M
|
$74.74 M
|
$66.57 M
|
$19.05 M
|
$18.07 M
|
$19.45 M
|
| EBITDA |
$276.61 M
|
$191.55 M
|
$223.46 M
|
$194.09 M
|
$200.47 M
|
$271.89 M
|
$205.54 M
|
$118.07 M
|
$99.94 M
|
$63.58 M
|
| EBITDA Ratio |
0.12 |
0.1 |
0.11 |
0.11 |
0.12 |
0.14 |
0.05 |
0.35 |
0.33 |
0.22 |
| Operating Income Ratio
|
0.01
|
-0
|
0.04
|
0.03
|
0.05
|
0.02
|
-0.01
|
0.22
|
0.2
|
0.13
|
| Total Other
Income/Expenses Net |
-$101.12 M
|
-$71.51 M
|
-$59,000.00
|
-$668,000.00
|
$7.35 M
|
-$7.38 M
|
$64.58 M
|
$2.22 M
|
$1.13 M
|
$755,000.00
|
| Income Before Tax |
-$78.30 M |
-$114.41 M |
$123.19 M |
$97.49 M |
$114.71 M |
$22.37 M |
$51.28 M |
$85.16 M |
$69.70 M |
$39.79 M |
| Income Before Tax Ratio
|
-0.03
|
-0.05
|
0.09
|
0.08
|
0.09
|
0.02
|
0.04
|
0.22
|
0.2
|
0.13
|
| Income Tax Expense |
-$48.64 M |
-$40.12 M |
$20.05 M |
$10.62 M |
$13.67 M |
-$6.42 M |
-$17.36 M |
$22.08 M |
$24.71 M |
$13.46 M |
| Net Income |
-$29.66 M |
-$74.29 M |
$103.14 M |
$86.87 M |
$101.04 M |
$28.79 M |
$68.64 M |
$63.08 M |
$44.99 M |
$26.34 M |
| Net Income Ratio |
-0.01 |
-0.03 |
0.08 |
0.07 |
0.08 |
0.02 |
0.05 |
0.17 |
0.13 |
0.09 |
| EPS |
-1.23 |
-3.11 |
4.86 |
4.16 |
4.9 |
1.33 |
3.5 |
3.9 |
2.84 |
1.72 |
| EPS Diluted |
-1.23 |
-3.11 |
4.74 |
4.02 |
4.69 |
1.33 |
3.29 |
3.66 |
2.73 |
1.68 |
| Weighted Average Shares
Out |
$24.09 M
|
$23.87 M
|
$21.21 M
|
$20.91 M
|
$20.63 M
|
$21.60 M
|
$19.61 M
|
$16.17 M
|
$15.85 M
|
$15.28 M
|
| Weighted Average Shares
Out Diluted |
$24.09 M
|
$23.87 M
|
$21.78 M
|
$21.59 M
|
$21.55 M
|
$21.60 M
|
$20.86 M
|
$17.25 M
|
$16.50 M
|
$15.65 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
